New Regulations in Vaud, Switzerland to Protect Youth Health

Jul.09.2024
New Regulations in Vaud, Switzerland to Protect Youth Health
Swiss canton of Vaud bans sale of e-cigarettes and vaporizers to under 18s, aiming to protect youth from smoking influences.

According to reports from LA COTE, the Swiss canton of Vaud has implemented a new regulation banning the sale of e-cigarettes and vaporizers to anyone under the age of 18, regardless of nicotine content. This measure is aimed at effectively protecting teenagers from the influence of smoking behaviors, while highlighting Vaud's high level of concern and protection for the health of young people.


According to new regulations, the sale of all e-cigarettes, heated tobacco products, and similar items will now be subject to the same legal oversight as traditional tobacco products. These laws include the Economic Activities Implementation Law, Advertising Procedures Law, and Public Place Smoking Ban, which were all passed by the full assembly last year.


Furthermore, the Swiss Economic Activities Act now requires all merchants to verify the age of buyers and submit relevant authorization requests when selling these products. The amendment to the Advertising Process Act also prohibits the display of advertisements for these products in public places and visible private properties (such as windows), especially in places where minors may come into contact with them.


During the transitional period of these regulations, businesses and local authorities are allowed enough time to make adjustments, all in response to a motion proposed by Green Party member Graziella Schaller aimed at reducing tobacco-related health costs and smoking rates.


The above are significant adjustments to the sale and advertising of tobacco products in the Swiss canton of Vaud under new regulations, aimed at ensuring the effective protection of public health, especially that of minors.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea said on Feb. 5 it has introduced “TEREA Shine Pearl,” a new TEREA stick designed for the IQOS ILUMA heated-tobacco device. The company said the product delivers a cool sensation and adds a fresh, fruity note when the capsule is crushed, bringing TEREA’s capsule-based lineup in South Korea to seven variants.
Feb.05 by 2FIRSTS.ai
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
British American Tobacco is facing a shareholder lawsuit in London alleging it failed to properly disclose to markets information about breaches of U.S. sanctions linked to its North Korea-related business. BAT agreed in 2023 to pay more than $635 million to U.S. authorities after a subsidiary admitted conspiring to violate U.S. sanctions by selling tobacco products to North Korea and committing bank fraud from 2007 to 2017.
Mar.05 by 2FIRSTS.ai
California: Stiiizy hit with another lawsuit alleging high-THC vapes marketed to teens
California: Stiiizy hit with another lawsuit alleging high-THC vapes marketed to teens
A new lawsuit in California state court accuses Stiiizy Inc. of steering high-THC vape products toward teens through youth-appealing branding and weak age verification, alleging the plaintiff’s underage use was followed by cannabis-induced psychosis-related symptoms and significant personal harm.
Feb.06 by 2FIRSTS.ai
Hampshire Trading Standards Seizes £138,000 Worth of Illegal Vapes and Tobacco in 2025
Hampshire Trading Standards Seizes £138,000 Worth of Illegal Vapes and Tobacco in 2025
According to Hampshire County Council, its Trading Standards team confiscated 116,000 illegal vape and tobacco products in 2025, worth an estimated £138,000 — a record annual haul.
Feb.02 by 2FIRSTS.ai